SOLAR-PROMOTION-GMBH
8.5.2024 17:40:34 CEST | Business Wire | Press release
The energy industry is undergoing a radical transformation. Renewable sources of energy have become increasingly profitable in recent years and are now the most economically viable solution for generating electricity. Deployment is accelerating and the technologies are becoming increasingly sophisticated. This has put renewables in the fast lane. Visionary companies are contributing to this development with modern technologies, ideas and concepts. The best and most innovative developments have been nominated for The smarter E AWARD 2024. The prize is awarded in five categories: Photovoltaics, Energy Storage, E-Mobility, Smart Integrated Energy and Outstanding Projects. The winners will be honored on the eve of The smarter E Europe on June 18 at 6:15pm at the International Congress Center München (ICM). Europe’s largest alliance of exhibitions for the energy industry unites four exhibitions (Intersolar Europe, ees Europe, Power2Drive Europe and EM-Power Europe) and will take place at Messe München from June 19–21.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240508604806/en/
The finalists for The smarter E AWARD 2024 have been announced in the five categories. (© Solar Promotion GmbH)
Intelligent, innovative, interdisciplinary – as Europe’s largest alliance of exhibitions for the energy industry, The smarter E Europe highlights key topics for a renewable 24/7 energy supply. The focus will be on solar energy, storage technologies, electromobility and grid and energy management. The smarter E AWARD is presented every year as part of this exhibition. The innovation prize recognizes companies and their products that are actively shaping tomorrow’s energy world. This year's finalists showcase clear trends – from artificial intelligence and digital twins to software-as-a-service solutions to higher performance and efficiency. These companies are the finalists of The smarter E AWARD 2024.
The finalists of the Photovoltaics category
- Aiko Energy (China)
- ArcelorMittal Construction (France)
- Euronergy (Netherlands)
- Institute for Solar Energy Research ISFH + Aerial PV Inspection (Germany)
- NexWafe (Germany)
- PVcase (Lithuania)
- Shenzhen Hopewind Electric (China)
- SMA Solar Technology (Germany)
- Solar Materials (Germany)
- WAVELABS Solar Metrology Systems (Germany)
The finalists of the Energy Storage category
- Contemporary Amperex Technology Co., Limited (CATL) (China)
- Cubenergy (China)
- Enphase Energy (USA)
- ESS Tech (USA)
- HagerEnergy (Germany)
- Jackery Technology (USA)
- Pfannenberg Europe (Germany)
- Sigenergy Technology Co., Ltd. (China)
- sonnen (Germany)
- Trina Storage (China)
The finalists of the E-Mobility category
- Autel Europe (Germany)
- Designwerk Technologies (Switzerland)
- EcoG (Germany)
- Huawei Digital Power (China)
- Road (Netherlands)
- SolarPaint by Apollo Power (Israel)
- Vector Informatik (Germany)
- XCharge Europe (Germany)
Finalists of the Smart Integrated Energy category
- CyberGrid (Germany)
- Delfos – Intelligence Asset Management (Spain)
- dvlp.energy (Germany)
- Entrix (Germany)
- Off-Grid Europe (Germany)
- PIONIERKRAFT (Germany)
- SolarEdge (Israel)
- suena (Germany)
- The Mobility House (Germany)
Finalists in the Outstanding Projects category
- 3SUN (Italy)
- Beijing HyperStrong Technology (China)
- Boreal Light (Germany)
- CALB Group (China)
- Huawei Digital Power (China)
- IO-Dynamics (Germany)
- LONGi Solar Technology (China)
- MaxSolar (Germany)
- Red Sea Global (Saudi Arabia)
- Siemens (Germany)
For more information, please visit:
www.TheSmarterE-award.com
The smarter E Europe
“Accelerating Integrated Energy Solutions“ – this is the motto of The smarter E Europe. Europe’s largest alliance of exhibitions for the energy industry puts the spotlight on cross-industry solutions for a renewable 24/7 energy supply covering electricity, heat and transport. The smarter E Europe unites four exhibitions and will take place from June 19–21, 2024 at Messe München.
More information: www.TheSmarterE.de
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240508604806/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Yubico Appoints Poupak Modirassari Enbom as Chief Marketing Officer to Accelerate Global Momentum and Drive Market Leadership30.3.2026 15:00:00 CEST | Press release
Yubico (NASDAQ STOCKHOLM: YUBICO), the creator of the most secure passkeys and a leading provider of hardware authentication security keys, today announced the appointment of Poupak Enbom as Chief Marketing Officer (CMO). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330278027/en/ Enbom joins Yubico at a pivotal moment as organizations worldwide accelerate the shift to phishing-resistant authentication and modern identity security in the age of AI. “We’re excited to welcome Poupak to Yubico,” said Jerrod Chong, acting chief executive officer, Yubico. “As the threat landscape evolves with AI-driven attacks and increasing automation, organizations are rethinking how they secure digital identities of both humans and AI agents at scale. She brings a unique combination of technical depth, global leadership, and customer-first mindset that will help us continue to expand our impact and support our customers and partners around
Westinghouse Celebrates Record-breaking 80 Years of Nuclear Fuel Manufacture at Springfields30.3.2026 14:00:00 CEST | Press release
Fuel manufactured at Springfields has generated enough energy to supply the UK’s electricity demand for 26 years, avoiding the emission of nearly 3 billion tonnes of CO2 The Westinghouse Springfields facility in Lancashire, UK, has marked a significant milestone as the oldest continuous nuclear fuel manufacturing site in the world, starting from its original license on the 28th, March 1946. The site was chosen by the UK Government to develop nuclear fuel for the world’s earliest civil nuclear power stations, as well as subsequent Magnox and Advanced Gas Reactors (AGR) reactors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330135973/en/ From left to right: Sophie Lemaire; Marc Chevrel; Rory O'Neill; Craig Boothby; and Robert Gofton, CEO at Nuclear Institute Across the last eight decades, the Springfields site has supported the UK nuclear fleet, manufacturing more than eight million AGR pins, sintering and pressing over 5
HistoSonics Treats First Patients Evaluating the Edison® Histotripsy System for the Treatment of Benign Prostatic Hyperplasia (BPH)30.3.2026 14:00:00 CEST | Press release
HistoSonics, the developer of the Edison® Histotripsy System and novel histotripsy therapy platform, today announced the successful treatments of the first patients in WOLVERINE, a prospective feasibility trial evaluating the Edison® Histotripsy System for the treatment of benign prostatic hyperplasia (BPH) at Prince of Wales Hospital in Hong Kong, a teaching hospital for The Chinese University of Hong Kong. The Edison System is a novel, non-invasive, image guided platform that uses the mechanical properties of focused ultrasound, called histotripsy, to destroy unwanted tissue without the need for invasive procedures, and with potentially fewer side effects than traditional, invasive therapies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330349844/en/ HistoSonics Non-Invasive Edison Histotripsy System. Image credit: HistoSonics WOLVERINE is a prospective, multi-center, single-arm feasibility trial designed to evaluate
Biocytogen Grants Taisho Pharmaceutical a License to its RenNano® Fully Human Heavy Chain-Only Antibody Discovery Platform30.3.2026 13:00:00 CEST | Press release
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies, today announced that it has entered into a platform license agreement with Taisho Pharmaceutical Co., Ltd. (“Taisho”), granting Taisho the right to access and use Biocytogen’s proprietary RenNano® fully human heavy chain-only antibody (HCAbs) discovery platform for its internal research and development programs. Under the terms of the agreement, Taisho will leverage RenNano® mice to enable the generation and screening of fully human HCAbs in vivo and to support downstream research associated with antibody discovery. Financial terms of the agreement have not been disclosed. “We are very pleased to enter into this collaboration with Taisho,” said Dr. Yuelei Shen, President and CEO of Biocytogen. “RenNano® is a robust and powerful fully human VHH discovery platform that pro
Meiji Seika Pharma Invests in Centivax to Develop Next Generation Universal Vaccine Platform30.3.2026 13:00:00 CEST | Press release
Meiji Seika Pharma Co., Ltd. (Head Office: Chuo-ku, Tokyo, President and Representative Director: Toshiaki Nagasato) today announced a strategic investment in Centivax, Inc. (Head Office: South San Francisco, CA, USA), a biotechnology company developing next-generation vaccines and therapies for universal protection against highly diverse targets. Centivax’s lead program includes a universal seasonal influenza vaccine (Centi-Flu 01) currently in a Phase 1 clinical study. Unlike conventional seasonal flu vaccines, which must be manufactured annually based on recommended candidate vaccine viruses, Centivax’s platform focuses both antibody and cellular immune responses on conserved regions of the influenza virus that cannot mutate and are shared across strains and distant subtypes. This approach aims to generate broad, consistent, and durable immunity against both seasonal and pandemic influenza. Meiji’s strategic investment aims to accelerate the advancement of Centi-Flu 01 and further a
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom